chr17-80118786-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The highest continental population minor allele frequency for c.2780C>T (p.Thr927Ile) in gnomAD v2.1.1 is 0.1317 in the African population. This is higher than the ClinGen LSD VCEP’s BA1 threshold (>0.01), therefore meeting the BA1 criterion. There is a ClinVar entry for this variant (Variation ID: 92482; 2 star review status) with six submitters classifying the variant as benign, and two as likely benign. In summary, this variant meets the criteria to be classified as benign for Pompe disease. GAA-specific ACMG/AMP criteria applied, as specified by the ClinGen LSD VCEP: BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA145778/MONDO:0009290/010

Frequency

Genomes: 𝑓 0.042 ( 363 hom., cov: 32)
Exomes 𝑓: 0.010 ( 484 hom. )

Consequence

GAA
NM_000152.5 missense

Scores

1
7
9

Clinical Significance

Benign reviewed by expert panel B:14

Conservation

PhyloP100: 2.32

Publications

19 publications found
Variant links:
Genes affected
GAA (HGNC:4065): (alpha glucosidase) This gene encodes lysosomal alpha-glucosidase, which is essential for the degradation of glycogen to glucose in lysosomes. The encoded preproprotein is proteolytically processed to generate multiple intermediate forms and the mature form of the enzyme. Defects in this gene are the cause of glycogen storage disease II, also known as Pompe's disease, which is an autosomal recessive disorder with a broad clinical spectrum. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
GAA Gene-Disease associations (from GenCC):
  • glycogen storage disease II
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
  • glycogen storage disease due to acid maltase deficiency, infantile onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • glycogen storage disease due to acid maltase deficiency, late-onset
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000152.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
NM_000152.5
MANE Select
c.2780C>Tp.Thr927Ile
missense
Exon 19 of 20NP_000143.2P10253
GAA
NM_001079803.3
c.2780C>Tp.Thr927Ile
missense
Exon 20 of 21NP_001073271.1P10253
GAA
NM_001079804.3
c.2780C>Tp.Thr927Ile
missense
Exon 19 of 20NP_001073272.1P10253

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GAA
ENST00000302262.8
TSL:1 MANE Select
c.2780C>Tp.Thr927Ile
missense
Exon 19 of 20ENSP00000305692.3P10253
GAA
ENST00000390015.7
TSL:1
c.2780C>Tp.Thr927Ile
missense
Exon 20 of 21ENSP00000374665.3P10253
GAA
ENST00000933406.1
c.2795C>Tp.Thr932Ile
missense
Exon 19 of 20ENSP00000603465.1

Frequencies

GnomAD3 genomes
AF:
0.0423
AC:
6434
AN:
152174
Hom.:
363
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.132
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0160
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.000962
Gnomad SAS
AF:
0.0511
Gnomad FIN
AF:
0.0117
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00451
Gnomad OTH
AF:
0.0258
GnomAD2 exomes
AF:
0.0188
AC:
4712
AN:
250594
AF XY:
0.0183
show subpopulations
Gnomad AFR exome
AF:
0.131
Gnomad AMR exome
AF:
0.00660
Gnomad ASJ exome
AF:
0.000497
Gnomad EAS exome
AF:
0.000653
Gnomad FIN exome
AF:
0.0105
Gnomad NFE exome
AF:
0.00416
Gnomad OTH exome
AF:
0.0116
GnomAD4 exome
AF:
0.0103
AC:
15039
AN:
1461080
Hom.:
484
Cov.:
33
AF XY:
0.0110
AC XY:
7984
AN XY:
726834
show subpopulations
African (AFR)
AF:
0.134
AC:
4487
AN:
33480
American (AMR)
AF:
0.00751
AC:
336
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000574
AC:
15
AN:
26136
East Asian (EAS)
AF:
0.000504
AC:
20
AN:
39700
South Asian (SAS)
AF:
0.0482
AC:
4157
AN:
86258
European-Finnish (FIN)
AF:
0.0101
AC:
533
AN:
52628
Middle Eastern (MID)
AF:
0.0109
AC:
63
AN:
5768
European-Non Finnish (NFE)
AF:
0.00406
AC:
4514
AN:
1112000
Other (OTH)
AF:
0.0151
AC:
914
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
994
1988
2982
3976
4970
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
284
568
852
1136
1420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0423
AC:
6448
AN:
152292
Hom.:
363
Cov.:
32
AF XY:
0.0420
AC XY:
3130
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.131
AC:
5459
AN:
41550
American (AMR)
AF:
0.0159
AC:
244
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3468
East Asian (EAS)
AF:
0.000965
AC:
5
AN:
5184
South Asian (SAS)
AF:
0.0519
AC:
250
AN:
4814
European-Finnish (FIN)
AF:
0.0117
AC:
124
AN:
10628
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00451
AC:
307
AN:
68028
Other (OTH)
AF:
0.0260
AC:
55
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
289
577
866
1154
1443
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0161
Hom.:
424
Bravo
AF:
0.0447
TwinsUK
AF:
0.00566
AC:
21
ALSPAC
AF:
0.00467
AC:
18
ESP6500AA
AF:
0.132
AC:
582
ESP6500EA
AF:
0.00349
AC:
30
ExAC
AF:
0.0219
AC:
2661
Asia WGS
AF:
0.0340
AC:
119
AN:
3478
EpiCase
AF:
0.00398
EpiControl
AF:
0.00320

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Glycogen storage disease, type II (5)
-
-
5
not specified (5)
-
-
3
not provided (3)
-
-
1
Cardiovascular phenotype (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.72
D
Eigen
Uncertain
0.40
Eigen_PC
Uncertain
0.34
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.76
T
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Pathogenic
3.0
M
PhyloP100
2.3
PrimateAI
Benign
0.39
T
PROVEAN
Uncertain
-3.1
D
REVEL
Uncertain
0.48
Sift
Benign
0.040
D
Sift4G
Benign
0.086
T
Polyphen
0.95
P
Vest4
0.050
MPC
0.13
ClinPred
0.024
T
GERP RS
4.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.19
gMVP
0.64
Mutation Taster
=85/15
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800315; hg19: chr17-78092585; COSMIC: COSV56408041; COSMIC: COSV56408041; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.